Roche offers to acquire all outstanding shares of Illumina, Inc. to further strengthen its leading role in diagnostics
25 January 2012 | By Roche
Roche announced that it is proposing to acquire all outstanding shares of Illumina, Inc...
List view / Grid view
25 January 2012 | By Roche
Roche announced that it is proposing to acquire all outstanding shares of Illumina, Inc...
23 January 2012 | By Roche
Establishment of a program to improve basic cancer care in Ethiopia...
19 December 2011 | By Roche
For the treatment of people with BRAF mutation-positive metastatic melanoma...
15 December 2011 | By Merck
New clinical trial will evaluate an investigational therapeutic regimen with VICTRELIS™ (boceprevir)...
15 December 2011 | By Roche
Roche announced that Sophie Kornowski-Bonnet has been appointed Head of Roche Partnering...
8 December 2011 | By Roche
6.1 month improvement in median progression free survival, from 12.4 to 18.5 months...
1 December 2011 | By Roche
Roche have announced that the cobas EGFR Mutation Test is now CE marked...
30 November 2011 | By Roche
Results from studies to be presented at SABCS...
18 November 2011 | By Roche
FDA Commissioner revokes approval of Avastin for treatment of mBC in the US...
9 November 2011 | By Roche
The vismodegib application has been granted priority review...
20 October 2011 | By Roche
Phase III trials underway to investigate ocrelizumab in two forms of MS...
17 October 2011 | By Roche
Acquisition aims to expand future treatment options for hepatitis C patients...
17 October 2011 | By Roche
Phase III study of a quicker route of administration shows comparable results to intravenous Herceptin...
10 October 2011 | By Roche
Monoclonal antibody gantenerumab removes amyloid plaques from the brain...
25 September 2011 | By Roche
Phase II study TDM4450g results announced...